Skip to content

A Behavioral Trial for the Treatment of Methamphetamine Dependence. - 1

Behavioral Trial for the Treatment of Methamphetamine Dependence

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00033124
Enrollment
50
Registered
2002-04-08
Start date
2001-07-31
Completion date
2002-06-30
Last updated
2017-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance-Related Disorders

Brief summary

The purpose of this study is to examine behavioral treatment for methamphetamine dependence.

Detailed description

To characterize meth. withdrawal symptoms using a multidimensional withdrawal questionnaire; to field test and investigate the effect of using an algorithm developed for discriminating between new use and residual carry-over of meth metabolites in urine and to evaluate the treatment response of meth. users to participation in the thrice weekly psychosocial protocol to be used as a platform in future pharmacotherapy trials.

Interventions

BEHAVIORALBehavior Therapy

Sponsors

National Institute on Drug Abuse (NIDA)
Lead SponsorNIH

Study design

Primary purpose
TREATMENT

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

Male or Female at least 18 yrs of age; DSM-4 diagnosis of methamphetamine (METH) dependence; be willing to comply with study procedures; verbalize understanding of consent and provide written consent and willingness to complete study procedures; be seeking treatment for METH dependence.

Exclusion criteria

Additional criteria available during screening at the site.

Design outcomes

Primary

MeasureTime frame
Withdrawal symptoms
New Use algorithm

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026